BioLife Solutions, Inc. Payments to Acquire Marketable Securities
BioLife Solutions, Inc. (BLFS) reported Payments to Acquire Marketable Securities of $22.69 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2023-11-09
- BioLife Solutions, Inc. payments to acquire marketable securities for the quarter ending 2023-09-30 was $6.96M, a 45.16% decline year-over-year.
- BioLife Solutions, Inc. payments to acquire marketable securities for the quarter ending 2023-06-30 was $7.53M, a 67.38% decline year-over-year.
- BioLife Solutions, Inc. payments to acquire marketable securities for the quarter ending 2023-03-31 was $8.20M.
- BioLife Solutions, Inc. payments to acquire marketable securities for the quarter ending 2022-09-30 was $12.69M.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 9 month |
|---|---|---|---|
| 2023-09-30 | $6.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $14.49M derived: sum of 2 quarters · filed 2023-11-09 | $22.69M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $7.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $15.73M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $8.20M 10-Q · filed 2023-05-11 | ||
| 2022-09-30 | $12.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $35.77M derived: sum of 2 quarters · filed 2023-11-09 | $35.77M 10-Q · filed 2023-11-09 |
| 2022-06-30 | $23.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $23.07M 10-Q · filed 2023-08-09 | |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |